Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell disulfidptosis regulator patterns guide intercellular communication of tumor microenvironment that contribute to kidney renal clear cell carcinoma progression and immunotherapy. | Front Immunol | 2024 | 38292868 | PubTator, text mining | PubMed |
| Follicular Lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases. | Mod Pathol | 2024 | 38290600 | PubTator, text mining | PubMed |
| Editorial: Advances in novel drugs and targets for hepatic and gastrointestinal diseases. | Front Pharmacol | 2024 | 38288440 | PubTator, text mining | PubMed |
| The Role of the CD28 Family Receptors in T-Cell Immunomodulation. | Int J Mol Sci | 2024 | 38279272 | PubTator, text mining | PubMed |
| SLCO4A1, as a novel prognostic biomarker of non‑small cell lung cancer, promotes cell proliferation and migration. | Int J Oncol | 2024 | 38275113 | PubTator, text mining | PubMed |
| Single-cell N6-methyladenosine-related genes function within the tumor microenvironment to affect the prognosis and treatment sensitivity in patients with gastric cancer. | Cancer Cell Int | 2024 | 38273348 | PubTator, text mining | PubMed |
| Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) deletion in myeloid cells augments cholestatic liver injury. | Sci Rep | 2024 | 38273071 | PubTator, text mining | PubMed |
| LIGHT/TNFSF14 Affects Adipose Tissue Phenotype. | Int J Mol Sci | 2024 | 38255789 | PubTator, text mining | PubMed |
| Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas. | Cancers (Basel) | 2024 | 38254810 | PubTator, text mining | PubMed |
| Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor Targeting. | Cancers (Basel) | 2024 | 38254772 | PubTator, text mining | PubMed |
| Construction of a Novel Damage-Associated Molecular-Pattern-Related Signature to Assess Lung Adenocarcinoma's Prognosis and Immune Landscape. | Biomolecules | 2024 | 38254708 | PubTator, text mining | PubMed |
| Single-cell landscape identifies the immunophenotypes and microenvironments of HBV-positive and HBV-negative liver cancer. | Hepatol Commun | 2024 | 38251896 | PubTator, text mining | PubMed |
| Inhibitors of Immune Checkpoints: Small Molecule- and Peptide-Based Approaches. | J Pers Med | 2024 | 38248769 | PubTator, text mining | PubMed |
| Identification of HSP90B1 in pan-cancer hallmarks to aid development of a potential therapeutic target. | Mol Cancer | 2024 | 38243263 | PubTator, text mining | PubMed |
| BTLA biology in cancer: from bench discoveries to clinical potentials. | Biomark Res | 2024 | 38233898 | PubTator, text mining | PubMed |
| Zinc Transporters Serve as Prognostic Predictors and their Expression Correlates with Immune Cell Infiltration in Specific Cancer: A Pan-cancer Analysis. | J Cancer | 2024 | 38230214 | PubTator, text mining | PubMed |
| Construction of an immune-related risk score signature for gastric cancer based on multi-omics data. | Sci Rep | 2024 | 38228846 | PubTator, text mining | PubMed |
| Low expression of PRRG2 in kidney renal clear cell carcinoma: an immune infiltration-associated prognostic biomarker. | Discov Oncol | 2024 | 38227081 | PubTator, text mining | PubMed |
| Deciphering the significance of anoikis in bladder cancer and systematic analysis of S100A7 as a potential therapeutic target. | Eur J Med Res | 2024 | 38217031 | PubTator, text mining | PubMed |
| Symptomatic Benign Prostatic Hyperplasia with Suppressed Epigenetic Regulator HOXB13 Shows a Lower Incidence of Prostate Cancer Development. | Cancers (Basel) | 2024 | 38201640 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=13